Therefore, focusing on the ability of the Keap1-Nrf2 signaling pathway that exerts intracellular resistance to ferroptosis could help to explore the specific mechanisms which breast cancer cells exhibit chemoresistance. The gene discussed is KEAP1; the disease is breast carcinoma.